Intussusception in canine recipients of hematopoietic cell grafts and surgical correction

Comparative Medicine

Volumn 57, Issue 3, 2007, Pages 287-291

  Yunusov, Murad Y ^a   Kerbauy, Fabio ^a   Abrams, Kraig ^a   Zellmer, Eustacia ^a   Spector, Michele ^a   Kuhr, Christian S ^a,b   Hwang, Billanna ^a   Storer, Barry ^a   Georges, George E ^a,b   Weigler, Benjamin J ^a   Storb, Rainer ^a,b   Nash, Richard A ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOG; GASTROINTESTINAL TOXICITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTUSSUSCEPTION; NEUTROPENIA; NONHUMAN; POSTOPERATIVE COMPLICATION; SMALL INTESTINE RESECTION; THROMBOCYTOPENIA;

ANIMALS; DOG DISEASES; DOGS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; ILEAL DISEASES; IMMUNOSUPPRESSIVE AGENTS; INTUSSUSCEPTION; MALE; RISK FACTORS; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 34250838049     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Abasiyanik A, Dasci Z, Yosunkaya A, Koseoglu B, Kuru N, Kaymakci A, Gundogan AH. 1997. Laparoscopic-assisted pneumatic reduction of intussusception. J Pediatr Surg 32:1147-1148.
2. Applewhite AA, Hawthorne JC, Cornell KK, Applewhite AA, Hawthorne JC, Cornell KK. 2001. Complications of enteroplication for the prevention of intussusception recurrence in dogs: 35 cases (1989-1999). J Am Vet Med Assoc 219:1415-1418.
3. Baron F, Storb R. 2004. Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review. Springer Semin lmmunopathol 26:71-94.
4. Bethge WA, Wilbur DS, Storb R, Hamlin DK, Santos EB, Brechbiel MW, Sandmaier BM. 2004. Radioimmunotherapy with Bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study. Transplantation 78:352-359.
5. Deeg HJ, Storb R, Appelbaum FR, Kennedy MS, Graham TC, Thomas ED. 1984. Combined immunosuppression with cyclosporine and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates. Transplantation 37:62-65.
6. Deeg HJ, Storb R, Weiden PL, Raff RF, Sale GE, Atkinson K, Graham TC, Thomas ED. 1982. Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host disease, and induction of tolerance. Transplantation 34:30-35.
7. Du Toit DF, Homan WP, Reece-Smith H, McShane P, French ME, Denton TG, Morris PJ, Du Toit DF, Homan WP, Reece-Smith H, McShane P, French ME, Denton TG, Morris PJ. 1981. Canine intestinal intussusception following renal and pancreatic transplantation. Vet Rec 108:34-35.
8. Emre S, Sumrani N, Youngelman D, Ding Z, Davis R, Hong JH. 1992. Orthotopic hepatic transplantation in the dog. J Invest Surg 5:51-59.
9. Hogan WJ, Little M-T, Zellmer E, Friedetzky A, Diaconescu R, Cisburne S, Lee R, Kuhr C, Storb R. 2003. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates. Biol Blood Marrow Transplant 9:489-495.
10. Klaus A, Weiss H, Klima G, Margreiter R, Pernthaler H. 1997. Cyclosporine causes an increase of contractile activity in rat small bowel. Transplant Proc 29:1801.
11. Kluwe WM, Page JC, Toft JD, Ridder WE, Chung H. 1990. Pharmacological and toxicological evaluation of orally administered pyridostigmine in dogs. Fundam Appl Toxicol 14:40-53.
12. McAnulty JF, Southard JH, Belzer FO. 1989. Prevention of postoperative intestinal intussusception by prophylactic morphine administration in dogs used for organ transplantation research. Surgery 105:494-495.
13. McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DC, Chauncey TR, Gooley TA, Hegenbart U, Nash RA, Radich J, Wagner JL, Minor S, Appelbaum FR, Bensinger WI, Bryant E, Flowers MED, Georges GE, Grumet FC, Kiem H-P, Torok-Storb B, Yu C, Blume KG, Storb RF. 2001. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97:3390-3400.
14. Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM, Przepiorka D, Davies S, Petersen FB, Bartels P, Buell D, Fitzsimmons W, Anasetti C, Storb R, Ratanatharathorn V. 2000. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood 96:2062-2068.
15. National Research Council. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academy Press.
16. Oakes MG, Lewis DD, Hosgood G, Beale BS. 1994. Enteroplication for the prevention of intussusception recurrence in dogs: 31 cases (1978-1992). J Am Vet Med Assoc 205:72-75.
17. Ochiai T, Gunji Y, Nagata M, Komori A, Asano T, Isono K, Ochiai T, Gunji Y, Nagata M, Komori A, Asano T, Isono K. 1993. Effects of rapamycin in experimental organ allografting. Transplantation 56:15-19.
18. Rallis TS, Papazoglou LG, Adamama-Moraitou KK, Prassinos NN. 2000. Acute enteritis or gastroenteritis in young dogs as a predisposing factor for intestinal intussusception: a retrospective study. J Vet Med A Physiol Pathol Clin Med 47:507-511.
19. Stepkowski SM, Stepkowski SM. 2003. Preclinical results of sirolimus treatment in transplant models (Review). Transplant Proc 35:219S-226S.
20. Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J, Hill R, Longton C, Lum L, Martin P, McGuffin R, Sanders J, Singer J, Stewart P, Sullivan K, Witherspoon R, Thomas ED. 1986. Marrow transplantation for severe aplastic anemia: Methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 68:119-125.
21. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED. 1986. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314:729-735.
22. Storb R, Raff RF, Appelbaum FR, Deeg HJ, Fitzsimmons W, Graham TC, Pepe M, Pettinger M, Sale G, Van Der Jagt R, Schuening FG. 1993. FK506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated DLA-nonidentical donors. Transplantation 56:800-807.
23. Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, Kiem H-P, Leisenring W, Shulman H. 1997. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89:3048-3054.
24. Storb R, Yu C, Zaucha JM, Deeg HJ, Georges G, Kiem H-P, Nash RA, McSweeney PA, Wagner JL. 1999. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 94:2523-2529.
25. Wagner JL, Burnett RC, DeRose SA, Francisco LV, Storb R, Ostrander EA. 1996. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation 62:876-877.
26. Wagner JL, Works JD, Storb R. 1998. DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing. Tissue Antigens 52:397-401.
27. Wilson GP, Burt JK, Wilson GP, Burt JK. 1974. Intussusception in the dog and cat: a review of 45 cases. J Am Vet Med Assoc 164:515-518.
28. Yu C, Seidel K, Nash RA, Deeg HJ, Sandmaier BM, Barsoukov A, Santos E, Storb R. 1998. Synergism between mycophenolatemofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts. Blood 91:2581-2587.
29. Yu C, Storb R, Deeg HJ, Graham TC, Schuening FG, Huss R, Seidel K, Fitzsimmons WE. 1996. Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation. Bone Marrow Transplant 17:649-653.